| HOME >> BIOLOGY >> TECHNOLOGY |
Product revenues $28,070 $15,781 $77,752 $43,482
Contract revenues 51 120 1,592 1,197
Total revenues 28,121 15,901 79,344 44,679
OPERATING EXPENSES:
Cost of product revenues 7,140 4,398 19,875 12,417
Research and development 6,939 5,643 20,667 16,037
Selling and marketing 10,837 9,484 35,030 26,377
General and administrative 6,505 4,488 18,635 12,763
Total operating expenses 31,421 24,013 94,207 67,594
Loss from operations (3,300) (8,112) (14,863) (22,915)
Other income (expense):
Interest income 369 1,021 1,438 2,149
Interest and other expense (91) (162) (330) (535)
Net loss ($3,022) ($7,253) ($13,755) ($21,301)
Basic and diluted net
loss per share ($0.11) ($0.26) ($0.49) ($0.81)
Shares used in computing
basic and diluted net
loss per share 28,331,505 28,119,786 28,270,776 26,287,177
Genomic Health, Inc.
Condensed Consolidated Balance Sheets
(in thousands)
September 30, December 31,
2008 2007
(Unaudited) (Audited)
Cash and cash equivalents $9,459 $39,164
Short-term investments 44,965 29,196
Accounts receivable, net 9,423 5,089
Prepaid expenses and other current assets 6,013 3,105
Tota
'/>"/>
| SOURCE Genomic Health, Inc. Copyright©2008 PR Newswire. All rights reserved |